Iris Gratz, PhD

Official position

2014 to present
Group leader for the immunology research group

2009-2014
Scientific team member at the University of California, San Francisco Laboratory: Abul K. Abbas
Research project: Skin immunity in conjunction with new auto-antigens

2006-2009
Scientific team member in the EB House Austria, Laboratory for Molecular Therapy

 

Research Project

• Immunotolerance in Gene Therapy

 

Scientific Career

2001-2005
Doctoral studies in Immunology
Position: Scientific team member at the University of Salzburg.
Thesis: A novel intracellular interaction partner of mIgE: HAX-1
Supervisor: Univ. Prof. Dr. Gernot Achatz
Graduation with honours

1995 - 2001
Degree studies Biology/Genetics at the University of Salzburg
Degree thesis: Genetic Immunisation in Allergy Therapy.
Supervisor: Univ. Prof. Dr. Josef Thalhamer
Graduation with honours

 

Honours and Scholarships

2008
Project funding for the research project: "The Immunology of Type VII Gene Therapy" endowed by the Salzburg Paracelsus Medical University.

Scholarship for clinical and molecular Epidermolysis bullosa research, endowed by the Epidermolysis Bullosa Network.

2007
VWR Dissertation Prize 2007
Bestowed by the Jury of the Austrian Society for Biochemistry and Molecular Biology. International Research Experience

07-09/2009
Inducing Immunological Tolerance by means of so-called DEC-205 Targeting.
Dermatology Research Laboratory, headed by Dr. Karsten Mahnke and Prof. A.H. Enk; Department of Dermatology, University Clinics of Heidelberg, Germany.

03-08/2001
Eirx Therapeutics Ltd. in Cork / Ireland
DNA Microarray Technology in the Research on Programmed Apoptose

 

Publications and Lectures for Scientific Congresses

11/2008
Application of skin antigens fused to a novel single chain fragment specific for murine DEC-205 to induce tolerance in a skin graft model. Annual meeting of the Network of Epidermolysis Bullosa, Freiburg, Germany

7/2007
HAX-1: An intracellular Interaction Partner of mIgE affecting BCR- Internalization. 32nd FEBS Congress, Vienna, Austria.